The growing demand for specific immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression platforms, including prokaryotic hosts, higher cell cultures, and